SANA
Sana Biotechnology, Inc.
Recent 8-K filings for SANA
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 11, 2026 20:08 UTC earnings item 2.02item 9.01
Sana Q1 net loss $47.2M, cash $101.1M; Mayo $25M equity; SC451/SG293 trials on track for 2026
source · SANA on sec.gov